Coverage
-
June 25, 2013
A New Jersey federal judge on Monday dismissed a Hoffmann-La Roche Inc. lawsuit contending Intas Pharmaceuticals Ltd. and a subsidiary infringed a patent for Roche's Xeloda cancer drug by seeking approval for a generic version of the treatment, after the parties reached a settlement.
1 other articles on this case.
View all »